|
🐜
|
Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48
12 auth.
Roberto Ortiz,
E. Dejesus,
H. Khanlou,
Evgeniy Voronin,
J. van Lunzen,
J. Andrade-Villanueva,
...
J. Fourie,
S. De Meyer,
M. de Pauw,
E. Lefebvre,
T. Vangeneugden,
S. Spinosa‐Guzman
|
8 |
2008 |
8
🐜
|
